Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
CeQur SA, a company focused on the development and commercialization of simple insulin delivery devices, announced that the PaQ? Insulin Delivery Device has received CE Mark approval. PaQ has demonstrated the safety and efficacy required for marketing in Europe.
PaQ is a discreet, wearable device that provides three days of consistent, basal insulin delivery as well as easy, on-demand bolus insulin for individuals with type 2 diabetes. The small device comprises a disposable insulin-infuser reservoir attached to a reusable insulin monitor. PaQ is simple to use, making it easy to train patients to start and stay on insulin therapy.
http://www.sacbee.com/2012/11/27/5012595/cequr-receives-ce-mark-for-paq.html
PaQ is a discreet, wearable device that provides three days of consistent, basal insulin delivery as well as easy, on-demand bolus insulin for individuals with type 2 diabetes. The small device comprises a disposable insulin-infuser reservoir attached to a reusable insulin monitor. PaQ is simple to use, making it easy to train patients to start and stay on insulin therapy.
http://www.sacbee.com/2012/11/27/5012595/cequr-receives-ce-mark-for-paq.html